The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS.
Kashi, Alex A, Davis, Ronald W, Phair, Robert D · Diagnostics (Basel, Switzerland) · 2019 · DOI
Quick Summary
This study proposes a new theory about what might cause ME/CFS based on how the body processes an amino acid called tryptophan. The researchers suggest that if two proteins involved in tryptophan processing don't work properly together, the body could get stuck in a harmful state that causes ME/CFS symptoms. According to their mathematical model, if we could find a way to reset tryptophan levels back to normal, patients might recover.
Why It Matters
This hypothesis provides one of the first mechanistic explanations for ME/CFS pathogenesis, moving beyond symptom-based treatment approaches. If validated experimentally, it could identify specific biomarkers for diagnosis and suggest targeted interventions to reset tryptophan metabolism. The model also explains why ME/CFS can appear in clusters and suggests the condition may be reversible under the right conditions.
Observed Findings
A database search identified 208 common damaging mutations in human enzymes, including four in IDO2
Mathematical modeling demonstrates that non-functional IDO2 combined with IDO1 substrate inhibition creates bistable tryptophan metabolism
The model identifies a critical threshold in cytosolic tryptophan abundance that determines which steady-state (normal or pathological) dominates
The model predicts that returning cytosolic tryptophan below the critical point would restore physiological steady-state
Inferred Conclusions
Common genetic mutations in tryptophan-metabolizing enzymes could predispose individuals to ME/CFS
Tryptophan metabolism can exist in two stable states, with the pathological state resembling ME/CFS
ME/CFS may be theoretically reversible if cytosolic tryptophan can be restored to below the critical threshold
The hypothesis explains the clustering of ME/CFS outbreaks through the combination of common genetic variants and triggering events
Remaining Questions
Does tryptophan metabolism actually show the proposed bistable behavior in real patient cells and tissues?
What specific exogenous perturbation (infection, stress, toxin, or treatment) could trigger the transition into the pathological state?
What This Study Does Not Prove
This study presents a mathematical model and does not provide experimental evidence from ME/CFS patient samples or cell cultures. The hypothesis has not been tested with labeled tryptophan or validated in any cell type. The model does not prove that tryptophan metabolism abnormalities actually cause ME/CFS in real patients, nor does it identify what exogenous perturbation might reset the system.